Comprehensive Risk Assessment of People With Silicosis: A Population-based Study
1 other identifier
observational
390
1 country
1
Brief Summary
Objectives: This study aims to explore the risk profiles among people with silicosis in Hong Kong underpinned by the Pittsburgh Mind-Body Center model. Design and subjects: This study will adopt a cross-sectional study design with sampling stratified by participants' degree of incapability. 320 Chinese people diagnosed with silicosis and registered with the Pneumoconiosis Compensation Fund Board will be recruited. Data collection: A demographic data sheet and the St. George's Respiratory Questionnaire will be used to collect the socio-demographic and clinical characteristics of the participants. The behavioral factors (smoking, drinking, physical activity level, consumption of vegetable and fruits and plasma vitamin C level) as well as the psychological risk factors (anxiety and depressive symptoms, and social support) will be examined by validated questionnaires. Biological and physiological parameters, including insulin resistance, C-reactive protein, hemoglobin, fasting blood glucose and lipid profiles, will be ascertained by fasting blood sample. Data analysis and expected outcomes: The findings of this study will create the database profile of the physical, psychosocial and disease specific aspects among people with silicosis in Hong Kong, subsequently forming the empirical basis of an intervention to tackle the identified modifiable risks among them.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2016
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 30, 2016
CompletedStudy Start
First participant enrolled
June 1, 2016
CompletedFirst Posted
Study publicly available on registry
June 9, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2017
CompletedJuly 6, 2018
July 1, 2018
10 months
May 30, 2016
July 5, 2018
Conditions
Outcome Measures
Primary Outcomes (14)
Respiratory symptoms and related physical limitation
examined by Hong Kong Chinese version of St. George's Respiratory Questionnaire
baseline
Psychological status
Anxiety and depression symptoms measured by the Chinese version of Hospital Anxiety and Depression Scale
baseline
Quality of life
examined by the SF-12v2
baseline
Social support
measured by the Chinese version of six-item Social Support Questionnaire
baseline
Body mass index
BMI in kg/m\^2
baseline
waist circumference
WC in cm
baseline
12-hour fasting lipid profile
total-cholesterol, HDL-Cholesterol, LDL-cholesterol and triglycerides (in mmol/L)
baseline
12-hour fasting glucose
FG in mmol/L
baseline
fasting insulin level
insulin in pmol/L
baseline
12 hour fasting ascorbic acid level
vit-C in mg/dL
baseline
fasting high sensitivity C-reactive protein level
hs-CRP in mg/L
baseline
hemoglobin level
hemoglobin in g/dL
baseline
smoking and drinking habits, vegetable and fruit intake
questions adopted from the Behavioral Risk Factor Surveillance of the Department of Health, Hong Kong SAR
baseline
Physical activity level
measured by the International Physical Activity Questionnaire - Short Form
baseline
Study Arms (1)
people with silicosis
Interventions
Eligibility Criteria
A convenience sample of 390 eligible participants registered with the Pneumoconiosis Compensation Fund Board will be recruited with stratification by their degree of incapacity \[(i) \<30%, (ii) 30% - 60%, and (iii) \>60%\], in which the minimal number of participants in each strata will be 30.
You may qualify if:
- Hong Kong Chinese-speaking residents and Chinese ethnicity;
- diagnosis of silicosis and confirmed by the Pneumoconiosis Medical Board
- registered with the Pneumoconiosis Compensation Fund Board (PCFB); and
- able and willing to give informed written consent
You may not qualify if:
- With medically diagnosed mental illness, including major depression, or
- with active pulmonary tuberculosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Nethersole School of Nursing, Chinese University of Hong Kong
Hong Kong SAR, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ho Yu CHENG, PhD, RN
The Nethersole School of Nursing, Chinese University of Hong Kong
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- post-doctoral fellow
Study Record Dates
First Submitted
May 30, 2016
First Posted
June 9, 2016
Study Start
June 1, 2016
Primary Completion
April 1, 2017
Study Completion
April 1, 2017
Last Updated
July 6, 2018
Record last verified: 2018-07
Data Sharing
- IPD Sharing
- Will not share